The
passage number is an important factor when designing the cell
line-based experiment. Although HT29 cells were widely used in the
laboratory for colorectal cancer studies, the impact of cell passage
number on the HT29 cells was still unknown. In this study, phenotypic
assay and metabolomic approach were applied to analyze the systemic
effects of passage numbers (passage 4, 10, and 16) on the HT29 cells.
The results showed that the increased cell passage number affected
the cell cycle distribution and also decreased the proliferation and
migration ability of HT29 cells. The metabolomic analysis coupled
with heatmap and hierarchical cluster analysis showed obvious metabolome
difference among the cells with different passage numbers, which was
related with 61 differential metabolites. Three metabolic pathways
were determined as the key pathways, and arginine participated in
two of them. In addition, it was found that arginine supplementation
could inhibit the proliferation ability of HT29 cells in vitro, and
a synergistic effect existed between arginine and cisplatin. In conclusion,
this study not only revealed the influence of passage numbers on the
HT29 cell but also provided an important reference that arginine has
the potential role to be developed as the cisplatin therapeutic adjuvant.